Mizuho Medy Co. Ltd. | Income Statement

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
3,997
4,083
4,962
5,624
6,425
Cost of Goods Sold (COGS) incl. D&A
1,361
1,432
1,782
1,975
2,118
Gross Income
2,637
2,651
3,180
3,649
4,307
SG&A Expense
2,172
2,263
2,654
2,799
3,086
EBIT
465
388
525
850
1,221
Unusual Expense
-
9
-
-
10
Non Operating Income/Expense
-
5
2
2
3
Interest Expense
6
5
3
1
1
Pretax Income
459
370
525
851
1,212
Income Tax
142
112
130
191
293
Consolidated Net Income
317
258
395
660
919
Net Income
317
258
395
660
919
Net Income After Extraordinaries
317
258
395
660
919
Net Income Available to Common
317
258
395
660
919
EPS (Basic)
37.51
30.31
41.49
69.30
96.51
Basic Shares Outstanding
8
9
10
10
10
EPS (Diluted)
37.51
30.31
41.49
69.30
96.51
Diluted Shares Outstanding
8
9
10
10
10
EBITDA
515
441
590
928
1,317
Non-Operating Interest Income
-
-
-
-
-

About Mizuho Medy Co.

View Profile
Address
5-4 Fujinoki-machi
Tosu Saga 841
Japan
Employees -
Website http://www.mizuho-m.co.jp
Updated 07/08/2019
Mizuho Medy Co., Ltd. engages in research and development, manufacture and distribution of in-vitro diagnostic products. It operates through the Hospital and Practitioner, and Over-the-Counter (OTC) and Other fields divisions. The Hospital and Practitioner field division covers the manufacture and distribution of biochemical test drugs and immune serun test drugs for medical institutions.